Global Pharmaceutical Drug Delivery Market, By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Other Drug Delivery); By Application (Infe
Description
Global Pharmaceutical Drug Delivery Market, By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Other Drug Delivery); By Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Diseases, Auto Immune Diseases and Others); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
Global Pharmaceutical Drug Delivery Market to Cross USD 2,433 Billion by 2028
The growth of the pharmaceutical drug delivery market can be ascribed to surge in the prevalence of chronic diseases throughout the world resulting in development of new and advanced technologies of medications and also pharmaceutical drug delivery systems. Moreover, the rising demand for pharmaceuticals coupled with emergence and adoption of new technologies in pharmaceutical manufacturing is driving the growth of the global pharmaceutical drug delivery market during the forecast period 2022-2028.
A recent study by the strategic consulting and market research firm; BlueWeave Consulting revealed that the Global Pharmaceutical Drug Delivery Market was worth USD 1,650.4 billion in 2021 and is projected to reach USD 2,433.7 billion by the year 2028, growing at a CAGR of 5.8% during the period of 2022-2028. This can be ascribed to the surge in the prevalence of chronic diseases throughout the world, resulting in the development of new and advanced technologies of medications and pharmaceutical drug delivery systems. Moreover, the rising demand for pharmaceuticals coupled with the emergence and adoption of new technologies in pharmaceutical manufacturing is driving the growth of the global pharmaceutical drug delivery market during the forecast period 2022-2028.
Growing Instances of Chronic Diseases Throughout the World Driving the Pharmaceutical Drug Delivery Market
The growth of the pharmaceutical drug delivery market is due to a surge in instances of chronic diseases, including asthma, Chronic Obstructive Pulmonary Disease (COPD), cancer, and several other diseases resulting in a high rate of morbidity globally. According to the Center for Disease Control and Prevention (CDC), six out of ten Americans have at least one chronic disease, such as heart disease, stroke, diabetes, or cancer. The World Health Organization stated that the prevalence of chronic disease would surge by 57% by 2020. The increment in the cases of chronic diseases may further lead to the development of new and advanced technologies of medications and also pharmaceutical drug delivery systems, thus propelling the growth of the pharmaceutical drug delivery market globally. Moreover, the rising demand for pharmaceuticals coupled with the emergence and adoption of new technologies in pharmaceutical manufacturing is expected to bolster the global pharmaceutical drug delivery market growth over the forecast period.
Infectious Disease Segment Account for The Largest Market Share In 2021
The pharmaceutical drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system diseases, autoimmune diseases, and others. Amidst the segmentation, the infectious disease segment accounted for the largest market share in 2021. Numerous chemical medications are used to treat common infectious diseases all over the world; thus, this category accounts for the majority of the revenue made by biotech and pharmaceutical businesses that supply resources to the healthcare industry. However, there has also been an increase in the incidence of respiratory diseases, autoimmune diseases, and central nervous system disorders in recent years.
The Asia-Pacific Region Expected to Grow with The Highest CAGR in the Global Pharmaceutical Drug Delivery Market.
In terms of regional analysis, the global pharmaceutical drug delivery market has been classified into North America, Europe, the Asia-Pacific, Latin America and the Middle East, and Africa. Amidst the segmentation, the Asia-Pacific region is expected to be the fastest growing market in the region during the forecast period 2022-2028. This can be attributed to the rising demand for pharmaceutical drug delivery owing to raised awareness about the use of pharmaceutical drug delivery products in the region. The growth of the markets in developing economies such as India, China, and Malaysia is fueled by the life science industry's ongoing evolution, which has resulted in a spike in awareness about the usage of pharmaceutical drug delivery systems.
Impact Of COVID-19 on the Global Pharmaceutical Drug Delivery Market
During the initial stages of the pandemic, with the rampant spread of COVID-19 and intensifying fear, drugs were stocked by various end users and patients. This boosted the growth of the pharmaceutical drug delivery market as several companies witnessed an increase in revenue in the first quarter of 2020 as compared to the first quarter of 2019. However, the stringent lockdown measures implemented throughout the world restricted patient movement and probable identification substantially. The healthcare institutions were overburdened with the influx of a large number of COVID-19 cases, thus impacting the availability of treatment for other health situations. Patients undergoing certain treatments experienced a remarkably long turnaround time due to the COVID 19 outbreak. After a few months, when it became clear that some other disorders could amplify the effects of the Covid-19 outcome, pharmaceutical items in all categories were resurrected to some extent.
Competitive Landscape
The global pharmaceutical drug delivery market is characterized by many local, regional, and global vendors. The key players operating in the global pharmaceutical drug delivery market are Novartis International AG, Pfizer INC, Johnson & Johnson, Hoffmann-LA Roche AG, Becton, Dickinson and Company, GlaxoSmithKline PLC, Merck & Co., INC, Sanofi, Bayer AG, 3M, Antares Pharma, INC, Amgen, INC, Abbvie INC, Genmab A/S, Gilead Sciences, INC, Boehringer Ingelheim, AstraZeneca PLC, Eli Lilly and Company, Teva Pharmaceutical Industries LTD and other prominent players. The players maintain their dominance in the market by investing in research and development activities, integrating the latest and advanced technologies into their products, and launching improved outcomes for the customers.
Don’t miss the business opportunity of the global pharmaceutical drug delivery market. Consult our analysts to gain crucial insights and facilitate your business growth.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the global pharmaceutical drug delivery market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global pharmaceutical drug delivery market ¬along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the market's growth drivers, challenges, and competitive dynamics.
About Us
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.
Global Pharmaceutical Drug Delivery Market to Cross USD 2,433 Billion by 2028
The growth of the pharmaceutical drug delivery market can be ascribed to surge in the prevalence of chronic diseases throughout the world resulting in development of new and advanced technologies of medications and also pharmaceutical drug delivery systems. Moreover, the rising demand for pharmaceuticals coupled with emergence and adoption of new technologies in pharmaceutical manufacturing is driving the growth of the global pharmaceutical drug delivery market during the forecast period 2022-2028.
A recent study by the strategic consulting and market research firm; BlueWeave Consulting revealed that the Global Pharmaceutical Drug Delivery Market was worth USD 1,650.4 billion in 2021 and is projected to reach USD 2,433.7 billion by the year 2028, growing at a CAGR of 5.8% during the period of 2022-2028. This can be ascribed to the surge in the prevalence of chronic diseases throughout the world, resulting in the development of new and advanced technologies of medications and pharmaceutical drug delivery systems. Moreover, the rising demand for pharmaceuticals coupled with the emergence and adoption of new technologies in pharmaceutical manufacturing is driving the growth of the global pharmaceutical drug delivery market during the forecast period 2022-2028.
Growing Instances of Chronic Diseases Throughout the World Driving the Pharmaceutical Drug Delivery Market
The growth of the pharmaceutical drug delivery market is due to a surge in instances of chronic diseases, including asthma, Chronic Obstructive Pulmonary Disease (COPD), cancer, and several other diseases resulting in a high rate of morbidity globally. According to the Center for Disease Control and Prevention (CDC), six out of ten Americans have at least one chronic disease, such as heart disease, stroke, diabetes, or cancer. The World Health Organization stated that the prevalence of chronic disease would surge by 57% by 2020. The increment in the cases of chronic diseases may further lead to the development of new and advanced technologies of medications and also pharmaceutical drug delivery systems, thus propelling the growth of the pharmaceutical drug delivery market globally. Moreover, the rising demand for pharmaceuticals coupled with the emergence and adoption of new technologies in pharmaceutical manufacturing is expected to bolster the global pharmaceutical drug delivery market growth over the forecast period.
Infectious Disease Segment Account for The Largest Market Share In 2021
The pharmaceutical drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system diseases, autoimmune diseases, and others. Amidst the segmentation, the infectious disease segment accounted for the largest market share in 2021. Numerous chemical medications are used to treat common infectious diseases all over the world; thus, this category accounts for the majority of the revenue made by biotech and pharmaceutical businesses that supply resources to the healthcare industry. However, there has also been an increase in the incidence of respiratory diseases, autoimmune diseases, and central nervous system disorders in recent years.
The Asia-Pacific Region Expected to Grow with The Highest CAGR in the Global Pharmaceutical Drug Delivery Market.
In terms of regional analysis, the global pharmaceutical drug delivery market has been classified into North America, Europe, the Asia-Pacific, Latin America and the Middle East, and Africa. Amidst the segmentation, the Asia-Pacific region is expected to be the fastest growing market in the region during the forecast period 2022-2028. This can be attributed to the rising demand for pharmaceutical drug delivery owing to raised awareness about the use of pharmaceutical drug delivery products in the region. The growth of the markets in developing economies such as India, China, and Malaysia is fueled by the life science industry's ongoing evolution, which has resulted in a spike in awareness about the usage of pharmaceutical drug delivery systems.
Impact Of COVID-19 on the Global Pharmaceutical Drug Delivery Market
During the initial stages of the pandemic, with the rampant spread of COVID-19 and intensifying fear, drugs were stocked by various end users and patients. This boosted the growth of the pharmaceutical drug delivery market as several companies witnessed an increase in revenue in the first quarter of 2020 as compared to the first quarter of 2019. However, the stringent lockdown measures implemented throughout the world restricted patient movement and probable identification substantially. The healthcare institutions were overburdened with the influx of a large number of COVID-19 cases, thus impacting the availability of treatment for other health situations. Patients undergoing certain treatments experienced a remarkably long turnaround time due to the COVID 19 outbreak. After a few months, when it became clear that some other disorders could amplify the effects of the Covid-19 outcome, pharmaceutical items in all categories were resurrected to some extent.
Competitive Landscape
The global pharmaceutical drug delivery market is characterized by many local, regional, and global vendors. The key players operating in the global pharmaceutical drug delivery market are Novartis International AG, Pfizer INC, Johnson & Johnson, Hoffmann-LA Roche AG, Becton, Dickinson and Company, GlaxoSmithKline PLC, Merck & Co., INC, Sanofi, Bayer AG, 3M, Antares Pharma, INC, Amgen, INC, Abbvie INC, Genmab A/S, Gilead Sciences, INC, Boehringer Ingelheim, AstraZeneca PLC, Eli Lilly and Company, Teva Pharmaceutical Industries LTD and other prominent players. The players maintain their dominance in the market by investing in research and development activities, integrating the latest and advanced technologies into their products, and launching improved outcomes for the customers.
Don’t miss the business opportunity of the global pharmaceutical drug delivery market. Consult our analysts to gain crucial insights and facilitate your business growth.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the global pharmaceutical drug delivery market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global pharmaceutical drug delivery market ¬along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the market's growth drivers, challenges, and competitive dynamics.
About Us
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.
Table of Contents
240 Pages
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Research Methodology
- 2.1. Qualitative Research
- 2.1.1. Primary & Secondary Research
- 2.2. Quantitative Research
- 2.3. Market Breakdown & Data Triangulation
- 2.3.1. Secondary Research
- 2.3.2. Primary Research
- 2.4. Breakdown of Primary Research Respondents, By Region
- 2.5. Assumption & Limitation
- 3. Executive Summary
- 4. Global Pharmaceutical Drug Delivery Market Insights
- 4.1. Industry Value Chain Analysis
- 4.2. DROC Analysis
- 4.2.1. Growth Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
- 4.3. Technological Advancement/Recent Development
- 4.4. Regulatory Framework
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Bargaining Power of Suppliers
- 4.5.2. Bargaining Power of Buyers
- 4.5.3. Threat of New Entrants
- 4.5.4. Threat of Substitutes
- 4.5.5. Intensity of Rivalry
- 5. Global Pharmaceutical Drug Delivery Market Overview
- 5.1. Market Size & Forecast by Value, 2018-2028
- 5.1.1. By Value (USD Million)
- 5.2. Market Share & Forecast
- 5.2.1. By Route Of Administration
- 5.2.1.1. Oral Drug Delivery
- 5.2.1.2. Injectable Drug Delivery
- 5.2.1.3. Topical Drug Delivery
- 5.2.1.4. Ocular Drug Delivery
- 5.2.1.5. Nasal Drug Delivery
- 5.2.1.6. Transmucosal Drug Delivery
- 5.2.1.7. Implantable Drug Delivery
- 5.2.1.8. Other Drug Delivery
- 5.2.2. By Application
- 5.2.2.1. Infectious Diseases
- 5.2.2.2. Cancer
- 5.2.2.3. Cardiovascular Diseases
- 5.2.2.4. Diabetes
- 5.2.2.5. Respiratory Diseases
- 5.2.2.6. Central Nervous System Diseases
- 5.2.2.7. Auto Immune Diseases
- 5.2.2.8. Other
- 5.2.3. By Region
- 5.2.3.1. North America
- 5.2.3.2. Europe
- 5.2.3.3. The Asia Pacific
- 5.2.3.4. Latin America
- 5.2.3.5. The Middle East and Africa
- 6. North America Pharmaceutical Drug Delivery Market
- 6.1. Market Size & Forecast by Value, 2018-2028
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Route Of Administration
- 6.2.2. By Application
- 6.2.3. By Country
- 6.2.3.1. United States
- 6.2.3.2. Canada
- 7. Europe Pharmaceutical Drug Delivery Market
- 7.1. Market Size & Forecast by Value, 2018-2028
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Route Of Administration
- 7.2.2. By Application
- 7.2.3. By Country
- 7.2.3.1. Germany
- 7.2.3.2. United Kingdom
- 7.2.3.3. Italy
- 7.2.3.4. France
- 7.2.3.5. Spain
- 7.2.3.6. Rest of Europe
- 8. The Asia Pacific Pharmaceutical Drug Delivery Market
- 8.1. Market Size & Forecast by Value, 2018-2028
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Route Of Administration
- 8.2.2. By Application
- 8.2.3. By Country
- 8.2.3.1. China
- 8.2.3.2. India
- 8.2.3.3. Japan
- 8.2.3.4. South Korea
- 8.2.3.5. Rest of Asia Pacific
- 9. Latin America Pharmaceutical Drug Delivery Market
- 9.1. Market Size & Forecast by Value, 2018-2028
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Route Of Administration
- 9.2.2. By Application
- 9.2.3. By Country
- 9.2.3.1. Brazil
- 9.2.3.2. Mexico
- 9.2.3.3. Rest of Latin America
- 10. The Middle East & Africa Pharmaceutical Drug Delivery Market
- 10.1. Market Size & Forecast by Value, 2018-2028
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Route Of Administration
- 10.2.2. By Application
- 10.2.3. By Country
- 10.2.3.1. Saudi Arabia
- 10.2.3.2. UAE
- 10.2.3.3. South Africa
- 10.2.3.4. Rest of Middle East & Africa
- 11. Competitive Landscape
- 11.1. List of Key Players and Their Offerings
- 11.2. Market Share Analysis, 2021
- 11.3. Competitive Benchmarking, By Operating Parameters
- 11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
- 12. Impact of Covid-19 on Global Pharmaceutical Drug Delivery Industry
- 13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
- 13.1. Novartis International AG
- 13.2. Pfizer INC
- 13.3. Johnson & Johnson
- 13.4. Hoffmann-LA Roche AG
- 13.5. Becton, Dickinson and Company
- 13.6. GlaxoSmithKline PLC
- 13.7. Merck & Co., INC
- 13.8. Sanofi
- 13.9. Bayer AG
- 13.10. 3M
- 13.11. Antares Pharma, INC
- 13.12. Amgen, INC
- 13.13. AbbVie INC
- 13.14. Genmab A/S
- 13.15. Gilead Sciences, INC
- 13.16. Boehringer Ingelheim
- 13.17. AstraZeneca PLC
- 13.18. Eli Lilly and Company
- 14. Key Strategic Recommendations
- *Financial information in case of non-listed companies will be provided as per availability
- **The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
- List Of Figures
- Figure 1: Global Pharmaceutical Drug Delivery Market Segmentation
- Figure 2: Global Pharmaceutical Drug Delivery Industry Value Chain Analysis
- Figure 3: Global Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 4: Global Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 5: Global Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 6: Global Pharmaceutical Drug Delivery Market Share (%), By Region, By Value, 2018-2028
- Figure 7: North America Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 8: North America Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 9: North America Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 10: North America Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028
- Figure 11: Europe Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 12: Europe Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 13: Europe Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 14: Europe Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028
- Figure 15: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 16: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 17: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 18: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028
- Figure 19: Latin America Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 20: Latin America Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 21: Latin America Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 22: Latin America Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028
- Figure 23: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028
- Figure 24: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028
- Figure 25: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028
- Figure 26: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028
- Figure 27: Global Pharmaceutical Drug Delivery Market Share Analysis, 2021
- List Of Tables
- Table 1: Global Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028
- Table 2: Global Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 3: Global Pharmaceutical Drug Delivery Market Size. By Region, By Value (USD Million), 2018-2028
- Table 4: North America Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028
- Table 5: North America Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 6: 28 North America Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028
- Table 7: Europe Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028
- Table 8: Europe Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 9: 40 Europe Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028
- Table 10: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028
- Table 11: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 12: 52 The Asia-Pacific Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028
- Table 13: Latin America Pharmaceutical Drug Delivery Market Size, By Route Of Administration, By Value (USD Million), 2018-2028
- Table 14: Latin America Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 15: Latin America Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028
- Table 16: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028
- Table 17: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028
- Table 18: 76 The Middle East & Africa Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028
- Table 19: List of Key Players and Their Offerings
- Table 20: Competitive Benchmarking, by Operating Parameters
- Table 21 Novartis International AG Company Overview
- Table 22 Novartis International AG Financial Overview
- Table 23 Pfizer INC Company Overview
- Table 24 Pfizer INC Financial Overview
- Table 25 Hoffmann-LA Roche AG Company Overview
- Table 26 Hoffmann-LA Roche AG Financial Overview
- Table 27 Becton, Dickinson and Company Overview
- Table 28 Becton, Dickinson and Company Financial Overview
- Table 29 Merck & Co., INC Company Overview
- Table 30 Merck & Co., INC Financial Overview
- Table 31 Bayer AG Company Overview
- Table 32 Bayer AG Financial Overview
- Table 33 3M Company Overview
- Table 34 3M Financial Overview
- Table 35 Antares Pharma, INC Company Overview
- Table 36 Antares Pharma, INC Financial Overview
- Table 37 Amgen, INC Company Overview
- Table 38 Amgen, INC Financial Overview
- Table 39 AbbVie INC Company Overview
- Table 40 AbbVie INC Financial Overview
- Table 41 Genmab A/S Company Overview
- Table 42 Genmab A/S Financial Overview
- Table 43 Gilead Sciences, INC Company Overview
- Table 44 Gilead Sciences, INC Financial Overview
- Table 45 Boehringer Ingelheim Company Overview
- Table 46 Boehringer Ingelheim Financial Overview
- Table 47 AstraZeneca PLC Company Overview
- Table 48 AstraZeneca PLC Financial Overview
- Table 49 Eli Lilly and Company Overview
- Table 50 Eli Lilly and Company Financial Overview
- Table 51 GlaxoSmithKline PLC Company Overview
- Table 52 GlaxoSmithKline PLC Company Financial Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
